Source: International Congress 2015 – Different data in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Burcu Arpinar Yigitbas (Istanbul, Turkey), Burcu Arpinar Yigitbas, Sibel Yurt, Baris Seker, Celal Satici, Ayse Filiz Kosar. COPD and pneumonia. Eur Respir J 2015; 46: Suppl. 59, 3660

Member's Comments

No comment yet.

Related content which might interest you: Distinguishing features of pneumonia and exacerbations in COPD Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015 Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<% Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 LATE-BREAKING ABSTRACT: Microbiology and radiology of pneumonia in COPD Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Survival in COPD patients with hospitalization due to exacerbation Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Impact of bronchiectasis on the course of COPD Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 ICS and risk of pneumonia in Swedish COPD patients: The ARCTIC study Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 Community acquired pneumonia in asthma patients Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 COPD and pseudomonas aeruginosa, an association Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Pneumonia or exacerbation of COPD? Source: Eur Respir Monogr 2015; 69: 185-196 Year: 2015 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 Etiological structure from sputum of patients with exacerbation of COPD Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Predictive factors of 90-days post-discharge COPD acute exacerbation’s recurrence Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016